EUVIMEDEUVIMED entdecken
Crossref

Small Interfering RNA Targeting Protein Z-Dependent Protease Inhibitor Improves Hemostasis in Von Willebrand Factor- and Factor X-Deficient Mice

Rim Hamze, Mariem Khamari, Kaitlyn R Calabro, Antoine Jehl, Christine Becker, Alexandre J Debacker, Natalie W Prusell, Damian Elle, Lijuan Pang, Ya Sun, Qian Wang, Qiugang Lei und 9 weitere

Thrombosis and Haemostasis · 28.10.2026

DOI: 10.1055/a-2979-5643 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thrombosis and Haemostasis, erschienen am 28.10.2026. Verfasst von Rim Hamze und 20 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris-Saclay, INSERM, Hémostase Inflammation Thrombose HITh U1176, France, Le Kremlin-Bicêtre. Die Arbeit nennt 37 Literaturangaben. Gefördert von: Tangram therapeutics.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nonfactor therapeutics have transformed the treatment paradigm in hemophilia A. Owing to their mode of action, these agents may also provide benefit for other rare bleeding disorders (RBDs) such as von Willebrand disease (VWD)-type 3 and factor X (FX) deficiency. Targeting protein Z-dependent protease inhibitor (ZPI), a natural anticoagulant, is a novel strategy to enhance hemostasis. We evaluated the effects of ZPI posttranscriptional silencing using a GalNAc-conjugated small interfering RNA (mTGM-148) in von Willebrand factor-deficient (Vwf KO) mice and in mice with strongly reduced FX levels (

Autor:innen und Institutionen

  • Université Paris-Saclay, INSERM, Hémostase Inflammation Thrombose HITh U1176, France, Le Kremlin-Bicêtre.
  • Tangram Therapeutics, London, United Kingdom.
  • WuXi AppTec, Switzerland, Couvet.
  • WuXi AppTec, China, Shanghai.
  • Centre Hospitalier Régional Universitaire de Nancy, France, Nancy.

ORCID-Profile: Caterina Casari, Elsa P Bianchini, Olivier D Christophe

Förderung

  • Tangram therapeutics

Zitieren

APA

Hamze, R., Khamari, M., Calabro, K. R., Jehl, A., Becker, C., Debacker, A. J., Prusell, N. W., Elle, D., Pang, L., Sun, Y., Wang, Q., Lei, Q., Chen, S., Guérin, A., McCluskey, G., Casari, C., Bianchini, E. P., Christophe, O. D., Whitmore, A. V., …, & Denis, C. V. (2026). Small Interfering RNA Targeting Protein Z-Dependent Protease Inhibitor Improves Hemostasis in Von Willebrand Factor- and Factor X-Deficient Mice. Thrombosis and Haemostasis. https://doi.org/10.1055/a-2979-5643

Vancouver

Hamze R, Khamari M, Calabro KR, Jehl A, Becker C, Debacker AJ, et al. Small Interfering RNA Targeting Protein Z-Dependent Protease Inhibitor Improves Hemostasis in Von Willebrand Factor- and Factor X-Deficient Mice. Thrombosis and Haemostasis. 2026. doi:10.1055/a-2979-5643

BibTeX
@article{Hamze2026,
  author = {Hamze, Rim and Khamari, Mariem and Calabro, Kaitlyn R and Jehl, Antoine and Becker, Christine and Debacker, Alexandre J and Prusell, Natalie W and Elle, Damian and Pang, Lijuan and Sun, Ya and Wang, Qian and Lei, Qiugang and Chen, Song and Guérin, Alice and McCluskey, Geneviève and Casari, Caterina and Bianchini, Elsa P and Christophe, Olivier D and Whitmore, Alan V and Lenting, Peter J and Denis, Cécile V},
  title = {Small Interfering RNA Targeting Protein Z-Dependent Protease Inhibitor Improves Hemostasis in Von Willebrand Factor- and Factor X-Deficient Mice},
  journal = {Thrombosis and Haemostasis},
  year = {2026},
  doi = {10.1055/a-2979-5643}
}
Kostenlos starten →